StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Citi
April 25, 2018 6:45 AM
Citi lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Bristol-Myers Squibb (BMY) Reports Clinical Trial Collaboration with Advantagene Inc.
April 27, 2018 7:16 AM